Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: pz who wrote (5171)	12/2/1999 9:28:00 AM
From: BDR	Respond to of 10293

<<Gel Tech LLC, a joint venture of Gum Tech International and BioDelivery Technologies, announced today that orders of Zicam(TM) have substantially exceeded five times the level of sales for the third quarter.>> From the GUMM quarterly report: Zicam sales reported for the quarter ended 9/30/99: $1,183,894 Income from operations attributable to Zicam: $275,599 "During the three months ended September 30, 1999, Gel Tech LLC recorded net sales of Zicam(TM) of approximately $1.18 million reflecting initial deliveries of the product to an increased number of retail establishments." So they have shipped at least five times as much to retailers, unless you have other information.

To: pz who wrote (5171)	12/2/1999 11:14:00 AM
From: Bob Trocchi	Respond to of 10293

pz... >>orders of Zicam(TM) have substantially exceeded five times the level of sales for the third quarter<< This type of data is always true as you fill the distribution channels. With all the stores that Dan is always talking about, I am surprised that the volume is only 5 times. The real question is how are the re-orders going. The limited reported evidence on this board indicates that at least some stores are not selling ZICAM in huge quantities. Truth will eventually win out. Bob T. Bob T.